title: Is connexin36 critical for GABAergic hypersynchronization in the hippocampus?
abstract: Synchronous bursting of cortical GABAergic interneurons is important in epilepsies associated with excitatory GABAergic signalling. If electrical coupling was critical for the generation of this pathological activity, then the development of selective blockers of connexin36-based interneuronal gap junctions could be of therapeutic value. We have addressed this issue in the 4-aminopyridine model of epilepsy in vitro by comparing GABAergic epileptiform currents and their sensitivity to gap junction blockers in wild-type vs. connexin36 knockout mice. Although electrical coupling was abolished in stratum lacunosum-moleculare interneurons from knockout animals, epileptiform currents were not eliminated. Furthermore, epileptiform currents propagated similarly across hippocampal layers in the two genotypic groups. Blockade of electrical coupling with carbenoxolone suppressed amplitude, frequency and half-width of the epileptiform currents both in wild-type and in knockout animals, whereas mefloquine had no effects. Carbenoxolone also depressed responses to exogenous and synaptic GABA application onto interneurons. We conclude that, in the 4-aminopyridine model of epilepsy in vitro, connexin36 is not critical for the generation of epileptiform discharges in GABAergic networks and that the observed antiepileptic effects of carbenoxolone are likely to be due to blockade of GABAA receptors and not of connexin36-based gap junctions. Lastly, because of its chemical structure and its effects on amplitude and kinetics of GABAergic currents, we tested the hypothesis that carbenoxolone acted via specific sites on GABAA receptors, such as the one mediating the effects of the neurosteroid pregnenolone sulfate, or the allosteric regulatory site of benzodiazepines/β-carbolines. Our results suggest that neither of these is involved.
authors.affiliation: Northwestern University Interdepartmental Neuroscience Program, Department of Physiology, Feinberg School of Medicine, 303 E Chicago Ave, Tarry Blg Rm 5-707, Chicago, IL 60611, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Beaumont
authors.forename: Gianmaria
authors.initials: G
authors.lastname: Maccaferri
mesh_terms: D015761:4-Aminopyridine / Q000633:toxicity; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002229:Carbenoxolone / Q000494:pharmacology; D017630:Connexins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D004827:Epilepsy / Q000139:chemically induced / Q000503:physiopathology; D017629:Gap Junctions / Q000187:drug effects / Q000502:physiology; D006624:Hippocampus / Q000502:physiology*; D066298:In Vitro Techniques; D007395:Interneurons / Q000502:physiology; D051379:Mice; D057507:Mice, 129 Strain; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008959:Models, Neurological; D018408:Patch-Clamp Techniques; D011284:Pregnenolone / Q000494:pharmacology; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology*; D000097004:Gap Junction delta-2 Protein
chemical_list: D015761:4-Aminopyridine; D000927:Anticonvulsants; D002229:Carbenoxolone; D017630:Connexins; D011284:Pregnenolone; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; D000097004:Gap Junction delta-2 Protein; C018370:pregnenolone sulfate